Tackling Inflammation at its Genetic Roots: Applying Personalized Medicine to Autoimmunity and Cancer
Yale researchers, led by professor of medicine Richard Bucala, have discovered that the transcription factor, ICBP90, governs the disease-causing aspect of a key inflammatory gene. This discovery has spurred new drug development efforts for patients of inflammatory and autoimmune diseases as well as cancer.